Benchmarking AI Risk Estimates in Prostate Cancer Against STAR-CAP | Urology Times
Daniel Spratt, MD, explains what the STAR-CAP cohort is, what an MMAI risk estimate represents, and why calibration benchmarking differs from ...
Read the original at Urology Times ↗
- Topics
- Healthcare
- Tracked via
- “AI Risks”
Same story, other outlets
- Using AI Risk Estimates in Prostate Cancer Treatment Decisions - Urology Times Urology Times · Oct 10, 2026